Tesa/IPA (10/10mg) Blend

Tesa/IPA (10/10mg) Blend: Product Description

The Tesamorelin/Ipamorelin blend combines two distinct synthetic research peptides investigated through complementary endocrine-signaling mechanisms. Tesamorelin is a 44-amino-acid analog of human growth hormone-releasing hormone, while Ipamorelin is a synthetic pentapeptide associated with growth hormone secretagogue receptor activity.

Controlled laboratory research involving this combination may examine GHRH-receptor binding, growth hormone secretagogue receptor interactions, intracellular cyclic AMP and calcium-associated signaling, receptor selectivity and communication between two distinct peptide-responsive pathways. Researchers may also evaluate how differences in peptide structure, receptor expression, stability and experimental concentration influence the observed response.

Tesamorelin and Ipamorelin retain separate chemical identities within the blend. Consequently, the combined product does not have one unified molecular formula, molecular weight or CAS number. Each component must be characterized independently, and any reported analytical specifications should reflect the exact chemical form documented by the product's Certificate of Analysis.

The 10/10 mg presentation contains 10 mg of Tesamorelin and 10 mg of Ipamorelin, producing a total nominal peptide content of 20 mg. Formula and mass values may vary if acetate salts, counterions or other formulation components are included.

Research Specifications

Tesamorelin: 10 mg

Molecular Formula: C221H366N72O67S

Molecular Weight: Approximately 5,135.9 g/mol

CAS Number: 218949-48-5

Amino Acid Count: 44

Compound Type: Synthetic GHRH analog

Research Target: GHRH receptor

Structural Characteristic: Modified N-terminal region

Ipamorelin: 10 mg

Molecular Formula: C38H49N9O5

Molecular Weight: Approximately 711.85 g/mol

CAS Number: 170851-70-4

Amino Acid Count: 5

Compound Type: Synthetic growth hormone secretagogue

Research Target: Growth hormone secretagogue/ghrelin receptor

Total Presentation: 20 mg

Blend Ratio: 10 mg Tesamorelin / 10 mg Ipamorelin

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE.